The Limb Salvage Center

Filter Your Results

 

News

 

Critical Limb Ischemia and Gangrene

Moderator: Lawrence A. Garcia, MD
Panel: Tony S. Das, MD, FACP, FACC; Robert A. Lookstein, MD; and Peter A. Schneider, MD

August 2017—CASE PRESENTATION A 76-year-old woman with a history of hypertension, hyperlipidemia, and chronic myeloid leukemia treated with hydroxyurea presents for a second opinion re…

Adjunctive Catheter-Directed Thrombolysis Evaluated for DVT

August 15, 2017 -- The Society for Vascular Surgery (SVS) announced the publication of an evaluation of thrombolysis using tissue plasminogen activator (tPA) in lower-extremit…

Swedish Study Compares Outcomes of Revascularized Patients With Intermittent Claudication or CLI

August 16, 2017 -- E. Baubeta Fridh, MD, et al published findings from a Swedish population-based study that sought to describe mid- to long-term amputation risk, cumulative i…

VentureMed Group Raises Financing to Support Product Development and Clinical Trials

August 15, 2017 -- VentureMed Group, Inc., which is a Toledo, Ohio -- based developer and commercializer of next-generation endovascular products to treat patients with periph…

Twelve-Month LIBERTY 360° Data Demonstrate Benefits of Endovascular Intervention in Patients With CLI

August 10, 2017 -- Cardiovascular Systems, Inc. (CSI) announced that 1-year data from its LIBERTY 360° clinical study were revealed by Jihad Mustapha, MD, in a late-breaki…

LIBERTY 360° Subanalysis Evaluates CSI's Diamondback 360 Peripheral OAS

August 10, 2017 -- Cardiovascular Systems, Inc. announced that a new subanalysis from the company's LIBERTY 360° study was presented as part of a late-breaking present…

Midterm Results Published From Pilot Study of LimFlow's pDVA System

August 1, 2017 -- LimFlow SA announced that midterm outcomes from the pilot study of the LimFlow percutaneous deep vein arterialization (pDVA) system for the treatment of no-o…

Surmodics Receives IDE Approval to Initiate Pivotal Trial of SurVeil DCB

July 26, 2017 -- Surmodics, Inc. announced that it has received an investigational device exemption (IDE) from the US Food and Drug Administration to initiate the TRANSCEND pi…

 

advertisement

 

Contact Info

For advertising rates and opportunities, contact:
Craig McChesney
484-581-1816
cmcchesney@bmctoday.com

Stephen Hoerst
484-581-1817
shoerst@bmctoday.com

Charles Philip
484-581-1873
cphillip@bmctoday.com

About Endovascular Today

Endovascular Today is a publication dedicated to bringing you comprehensive coverage of all the latest technology, techniques, and developments in the endovascular field. Our Editorial Advisory Board is composed of the top endovascular specialists, including interventional cardiologists, interventional radiologists, vascular surgeons, neurologists, and vascular medicine practitioners, and our publication is read by an audience of more than 22,000 members of the endovascular community.